Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 978.00
Bid: 980.00
Ask: 984.00
Change: -6.00 (-0.61%)
Spread: 4.00 (0.408%)
Open: 971.00
High: 997.00
Low: 971.00
Prev. Close: 984.00
CVSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Response to CMA review into veterinary market

7 Sep 2023 10:50

RNS Number : 7397L
CVS Group plc
07 September 2023
 

7 September 2023

 

CVS Group plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

 

 

Response to CMA review into the veterinary services market

 

CVS, the UK quoted veterinary group and a leading provider of integrated veterinary services, notes that the Competition and Markets Authority ("CMA") has launched a review into the UK veterinary services market for household pets. We always work closely with our regulators and we and our colleagues will support the CMA review.

 

Our purpose at CVS is to give the best possible care to animals and we continually invest in our colleagues, practices and clinical equipment to enhance the care to our clients and their patients. The Group has always sought to ensure its prices are appropriate and reflect fair value to our clients. Our pricing structures are set by clinicians to ensure these align with our purpose.

 

As the CMA have recognised, there continues to be a significant shortage of vets in the UK and employment costs represent the most significant proportion of our cost base. Our pricing reflects this and other inflationary pressures experienced in recent years.

 

We have a clear strategy to continue to expand our network and to improve clinical care through investment in facilities, equipment, technology and our people.

 

We will announce our full year results on 21 September 2023.

 

 

 

CVS Group plc via Camarco

Richard Fairman, CEO

Ben Jacklin, Deputy CEO

Robin Alfonso, CFO

 

Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418 8900

Adrian Trimmings / Michael Burke / Andrew Clark / Lalit Bose

 

Berenberg (Joint Broker) +44 (0)20 3207 7800

Toby Flaux / Ben Wright / James Thompson / Milo Bonser

 

Camarco (Financial PR) cvsg@camarco.co.uk

Geoffrey Pelham-Lane +44 (0)7733 124 226

Ginny Pulbrook +44 (0)7961 315 138

Rosie Driscoll +44 (0)7752 245 008

 

 

 

 

About CVS Group plc (www.cvsukltd.co.uk)

CVS Group is an AIM-quoted fully-integrated provider of veterinary services in the UK, with practices in Australia, the Netherlands and the Republic of Ireland. CVS is focused on providing high quality clinical services to its customers and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group has c.500 veterinary practices across its four markets, including nine specialist referral hospitals and 39 dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties), Crematoria (providing pet cremation and clinical waste disposal for CVS and third-party practices), Buying Groups and the Group's online retail business ("Animed Direct").

The Group employs c.8,700 personnel, including c.2,250 veterinary surgeons and c.3,200 nurses.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUPURCBUPWUBM
Date   Source Headline
30th Nov 20184:53 pmRNSHolding(s) in Company
29th Nov 20181:48 pmRNSResult of AGM
29th Nov 20187:00 amRNSAnnual General Meeting Trading Update
14th Nov 201811:48 amRNSHolding(s) in Company
12th Nov 20183:56 pmRNSHolding(s) in Company
12th Nov 20183:50 pmRNSHolding(s) in Company
6th Nov 20185:11 pmRNSPosting of Annual Report and Notice of AGM
5th Nov 20188:05 amRNSExercise of Options, Directors' Dealing and TVR
31st Oct 20185:32 pmRNSTotal Voting Rights
24th Oct 201810:43 amRNSHolding(s) in Company
16th Oct 201812:51 pmRNSLong Term Incentive Plan Awards
15th Oct 20187:00 amRNSHolding(s) in Company
4th Oct 20187:00 amRNSExercise of Options and Total Voting Rights
27th Sep 20187:00 amRNSPreliminary Results
21st Sep 20184:21 pmRNSHolding(s) in Company
21st Sep 20184:21 pmRNSHolding(s) in Company
24th Aug 201812:22 pmRNSHolding(s) in Company
23rd Aug 20182:56 pmRNSHolding(s) in Company
21st Aug 20184:22 pmRNSHolding(s) in Company
21st Aug 20183:32 pmRNSHolding(s) in Company
2nd Aug 20187:00 amRNSTrading Statement & Board Update
31st Jul 20185:45 pmRNSExercise of Options and Total Voting Rights
20th Jul 20187:00 amRNSBoard Changes and Notice of Trading Update
10th Jul 201810:35 amRNSHolding(s) in Company
6th Jul 20185:11 pmRNSHolding(s) in Company
2nd Jul 20184:51 pmRNSDirector/PDMR Shareholding
2nd Jul 20184:46 pmRNSTotal Voting Rights
2nd Jul 20183:05 pmRNSHolding(s) in Company
19th Jun 20187:00 amRNSBlock listing Interim Review
7th Jun 20184:18 pmRNSHolding(s) in Company
31st May 20183:40 pmRNSExercise of Options and Total Voting Rights
22nd May 20182:47 pmRNSHolding(s) in Company
18th May 20184:33 pmRNSHolding(s) in Company
10th May 20182:33 pmRNSHolding(s) in Company
4th May 20185:31 pmRNSHolding(s) in Company
30th Apr 20184:47 pmRNSTotal Voting Rights
24th Apr 20183:13 pmRNSHolding(s) in Company
23rd Apr 20185:55 pmRNSHolding(s) in Company
10th Apr 20182:26 pmRNSExercise of Options & TVR
4th Apr 201812:05 pmRNSDirector/PDMR and PCA Shareholding
3rd Apr 20188:20 amRNSHolding(s) in Company
29th Mar 20187:00 amRNSTotal Voting Rights
28th Mar 20184:42 pmRNSExercise of Options, Director/PCA Dealing & TVR
20th Mar 20183:06 pmRNSExercise of Options, Directors' dealings and TVR
1st Mar 20183:30 pmRNSTotal Voting Rights
21st Feb 20184:17 pmRNSHolding(s) in Company
16th Feb 20185:36 pmRNSResult of Placing
16th Feb 201812:45 pmRNSPlacing Update
16th Feb 201811:05 amRNSClose of Accelerated Bookbuild
16th Feb 20187:01 amRNSProposed Accelerated Bookbuild

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.